Search results for: Mental Health
Filter search results
How Much Should We Spend on the NHS?
1 July 2004
…Office of Health Economics, the King’s Fund and the Centre for Health Economics was held on 13 November 2002 to critically examine the assumptions, estimates and models underpinning the recommendations…
Assessing Trends in SMC Advice Decisions (October 2009- September 2015)
1 February 2016
…appeared that the economic case outweighed the wider considerations presented by PACE groups (e.g. these medicines had high incremental cost-effectiveness ratios). The steady increase in PAS agreements and the upward…
Establishing a Reasonable Price for an Orphan Drug
1 July 2018
…Towse, along with Professor Mike Drummond from University of York, addresses that question, based on the proposition that, although society may be willing to sacrifice some health gain overall to…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment
1 April 2019
…by the 2018 Seventieth World Health Assembly WHA70.12 on Cancer prevention and control in the context of an integrated approach. The Report dismisses value assessment and the fundamental role of…
It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?
1 December 2021
…the best use to be made of the drug. If payers refuse to reimburse new treatments on the grounds of lack of good evidence of incremental effectiveness, there is likely…
Grace Hampson
28 May 2014
Grace is an economist with a strong interest in value assessment, pricing and reimbursement, and public health economics. She is team leader for OHE’s Policy, Organisation and Incentives in Health…
Nadine Henderson
26 September 2019
…environmental sustainability of the pharmaceutical industry and health systems. Her projects in this area include supporting the era of green pharmaceuticals in the UK and estimating the health and cost…
Supporting the Era of Green Pharmaceuticals in the UK
1 November 2022
…the challenge of reducing the NHS’s carbon footprint. Share this: Download publication Tackling the climate crisis is an international priority. Healthcare has a high carbon footprint, accounting for 5% of…
The Economics of Antibiotics – Part 1: Why NICE and NHS England are Testing an Innovative HTA and Payment Model to Tackle Antimicrobial Resistance
12 October 2022
…number of smaller antibiotic companies [2,8]. Health economists have developed a mechanism to strengthen incentives for antibiotic Development Health economists, recognising the antibiotic market’s failure, have proposed the ‘delinked model’…